Harvard Bioscience Inc (HBIO) — Cash Flow Quality Index
Harvard Bioscience Inc (HBIO) has a Cash Flow Quality Index of 95.83x as of December 2024. Operating cash flow of $1.73 Million exceeds net income of $18.00K, indicating high earnings quality where cash backs reported profits. Explore Harvard Bioscience Inc (HBIO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Harvard Bioscience Inc Cash Flow Quality Index (2002–2014)
Historical Cash Flow Quality Index for Harvard Bioscience Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see HBIO cash flow conversion.
Annual Cash Flow Quality Index for Harvard Bioscience Inc (2002–2014)
Year-by-year earnings quality comparison for Harvard Bioscience Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.85x | $4.35 Million | $2.35 Million | ▼ -45.7% |
| 2012 | 3.40x | $8.06 Million | $2.37 Million | ▲ +104.3% |
| 2011 | 1.67x | $6.35 Million | $3.81 Million | ▲ +157.6% |
| 2010 | 0.65x | $12.29 Million | $19.02 Million | ▼ -71.7% |
| 2009 | 2.28x | $16.51 Million | $7.23 Million | ▼ -58.5% |
| 2008 | 5.50x | $9.20 Million | $1.67 Million | ▲ +12.0% |
| 2004 | 4.91x | $11.44 Million | $2.33 Million | ▲ +931.6% |
| 2003 | 0.48x | $2.03 Million | $4.26 Million | ▼ -56.1% |
| 2002 | 1.08x | $799.46K | $737.33K | — |